Stephanie Monaghan Obrien - Net Worth and Insider Trading

Stephanie Monaghan Obrien Net Worth

The estimated net worth of Stephanie Monaghan Obrien is at least $9,928 dollars as of 2025-06-27. Stephanie Monaghan Obrien is the Director of Aduro Biotech Inc and owns about 680 shares of Aduro Biotech Inc (ADRO) stock worth over $9,928. Details can be seen in Stephanie Monaghan Obrien's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephanie Monaghan Obrien has not made any transactions after 2015-04-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Stephanie Monaghan Obrien

To

Stephanie Monaghan Obrien Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stephanie Monaghan Obrien owns 2 companies in total, including Aduro Biotech Inc (ADRO) , and Chinook Therapeutics Inc (KDNY) .

Click here to see the complete history of Stephanie Monaghan Obrien’s form 4 insider trades.

Insider Ownership Summary of Stephanie Monaghan Obrien

Ticker Company Transaction Date Type of Owner
ADRO Aduro Biotech Inc 2020-05-05 director
KDNY Chinook Therapeutics Inc 2018-06-06 director

Stephanie Monaghan Obrien Latest Holdings Summary

Stephanie Monaghan Obrien currently owns a total of 1 stock. Stephanie Monaghan Obrien owns 680 shares of Aduro Biotech Inc (ADRO) as of April 20, 2015, with a value of $9,928.

Latest Holdings of Stephanie Monaghan Obrien

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ADRO Aduro Biotech Inc 2015-04-20 680 14.60 9,928

Holding Weightings of Stephanie Monaghan Obrien


Stephanie Monaghan Obrien Form 4 Trading Tracker

According to the SEC Form 4 filings, Stephanie Monaghan Obrien has made a total of 0 transactions in Aduro Biotech Inc (ADRO) over the past 5 years. The most-recent trade in Aduro Biotech Inc is the acquisition of 680 shares on April 20, 2015, which cost Stephanie Monaghan Obrien around $57,800.

Insider Trading History of Stephanie Monaghan Obrien

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stephanie Monaghan Obrien Trading Performance

GuruFocus tracks the stock performance after each of Stephanie Monaghan Obrien's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephanie Monaghan Obrien is -35.28%. GuruFocus also compares Stephanie Monaghan Obrien's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephanie Monaghan Obrien within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Stephanie Monaghan Obrien's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Stephanie Monaghan Obrien

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -30.21 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -31.42 LIMIT LIMIT LIMIT LIMIT LIMIT

Stephanie Monaghan Obrien Ownership Network

Ownership Network List of Stephanie Monaghan Obrien

No Data

Ownership Network Relation of Stephanie Monaghan Obrien

Insider Network Chart


Stephanie Monaghan Obrien Owned Company Details

What does Aduro Biotech Inc do?

Who are the key executives at Aduro Biotech Inc?

Stephanie Monaghan Obrien is the director of Aduro Biotech Inc. Other key executives at Aduro Biotech Inc include director & President & CEO Eric Dobmeier , 10 percent owner Versant Voyageurs I, L.p. , and 10 percent owner Versant Voyageurs I Parallel, L.p. .

Aduro Biotech Inc (ADRO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aduro Biotech Inc (ADRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aduro Biotech Inc (ADRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aduro Biotech Inc (ADRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aduro Biotech Inc Insider Transactions

No Available Data

Stephanie Monaghan Obrien Mailing Address

Above is the net worth, insider trading, and ownership report for Stephanie Monaghan Obrien. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Stephanie Monaghan Obrien's mailing address is: Berkeley Ca 94710.